These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 33441913)

  • 1. In silico analysis of epitope-based vaccine candidate against tuberculosis using reverse vaccinology.
    Bibi S; Ullah I; Zhu B; Adnan M; Liaqat R; Kong WB; Niu S
    Sci Rep; 2021 Jan; 11(1):1249. PubMed ID: 33441913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoinformatics and structural aided approach to develop multi-epitope based subunit vaccine against Mycobacterium tuberculosis.
    Sethi G; Varghese RP; Lakra AK; Nayak SS; Krishna R; Hwang JH
    Sci Rep; 2024 Jul; 14(1):15923. PubMed ID: 38987613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing of a Chimeric Vaccine Using EIS (Rv2416c) Protein Against Mycobacterium tuberculosis H37Rv: an Immunoinformatics Approach.
    Logesh R; Lavanya V; Jamal S; Ahmed N
    Appl Biochem Biotechnol; 2022 Jan; 194(1):187-214. PubMed ID: 34817805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reverse vaccinology approach to design a multi-epitope vaccine construct based on the Mycobacterium tuberculosis biomarker PE_PGRS17.
    Moodley A; Fatoba A; Okpeku M; Emmanuel Chiliza T; Blessing Cedric Simelane M; Pooe OJ
    Immunol Res; 2022 Aug; 70(4):501-517. PubMed ID: 35554858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Immunoinformatics-Based Study of Mycobacterium tuberculosis Region of Difference-2 Uncharacterized Protein (Rv1987) as a Potential Subunit Vaccine Candidate for Preliminary Ex Vivo Analysis.
    Arega AM; Dhal AK; Pattanaik KP; Nayak S; Mahapatra RK
    Appl Biochem Biotechnol; 2024 Apr; 196(4):2367-2395. PubMed ID: 37498378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of multi-epitope based vaccine against
    Nayak SS; Sethi G; Ramadas K
    J Biomol Struct Dyn; 2023; 41(23):14116-14134. PubMed ID: 36775659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immunoinformatics approach to design a multi-epitope vaccine against Mycobacterium tuberculosis exploiting secreted exosome proteins.
    Sharma R; Rajput VS; Jamal S; Grover A; Grover S
    Sci Rep; 2021 Jul; 11(1):13836. PubMed ID: 34226593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA vaccine with discontinuous T-cell epitope insertions into HSP65 scaffold as a potential means to improve immunogenicity of multi-epitope Mycobacterium tuberculosis vaccine.
    Wu M; Li M; Yue Y; Xu W
    Microbiol Immunol; 2016 Sep; 60(9):634-45. PubMed ID: 27531823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoinformatics and Reverse Vaccinology Driven Predication of a Multi-epitope Vaccine against
    Hussain Z; Hayat C; Shahab M; Sikandar R; Bibi H; Kamil A; Zheng G; Liang C
    Curr Pharm Des; 2023; 29(19):1504-1515. PubMed ID: 37073655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptides-Based Vaccine MP3RT Induced Protective Immunity Against
    Gong W; Liang Y; Mi J; Jia Z; Xue Y; Wang J; Wang L; Zhou Y; Sun S; Wu X
    Front Immunol; 2021; 12():666290. PubMed ID: 33981313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitope promiscuity and population coverage of Mycobacterium tuberculosis protein antigens in current subunit vaccines under development.
    Ong E; He Y; Yang Z
    Infect Genet Evol; 2020 Jun; 80():104186. PubMed ID: 31923726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoinformatics design of a novel epitope-based vaccine candidate against dengue virus.
    Fadaka AO; Sibuyi NRS; Martin DR; Goboza M; Klein A; Madiehe AM; Meyer M
    Sci Rep; 2021 Oct; 11(1):19707. PubMed ID: 34611250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling mRNA-based vaccine YFV.E1988 against yellow fever virus E-protein using immuno-informatics and reverse vaccinology approach.
    Khan NT; Zinnia MA; Islam ABMMK
    J Biomol Struct Dyn; 2023 Mar; 41(5):1617-1638. PubMed ID: 34994279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2.
    Tahir Ul Qamar M; Shahid F; Aslam S; Ashfaq UA; Aslam S; Fatima I; Fareed MM; Zohaib A; Chen LL
    Infect Dis Poverty; 2020 Sep; 9(1):132. PubMed ID: 32938504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoinformatics analysis of antigenic epitopes and designing of a multi-epitope peptide vaccine from putative nitro-reductases of Mycobacterium tuberculosis DosR.
    Shiraz M; Lata S; Kumar P; Shankar UN; Akif M
    Infect Genet Evol; 2021 Oct; 94():105017. PubMed ID: 34332157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis: Routes of immunization and TLR agonists critically impact vaccine's efficacy.
    Gupta N; Vedi S; Kunimoto DY; Agrawal B; Kumar R
    Vaccine; 2016 Nov; 34(46):5677-5688. PubMed ID: 27693020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prioritization of potential vaccine candidates and designing a multiepitope-based subunit vaccine against multidrug-resistant Salmonella Typhi str. CT18: A subtractive proteomics and immunoinformatics approach.
    Chand Y; Singh S
    Microb Pathog; 2021 Oct; 159():105150. PubMed ID: 34425197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine.
    Gupta N; Garg S; Vedi S; Kunimoto DY; Kumar R; Agrawal B
    Front Immunol; 2018; 9():2371. PubMed ID: 30386336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A multi-stage and multi-epitope vaccine against Mycobacterium tuberculosis based on an immunoinformatics approach].
    Ning Y; Cai Y; Liu X; Gu C; Meng X; Qiao J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Jun; 39(6):494-500. PubMed ID: 37340917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope-driven TB vaccine development: a streamlined approach using immuno-informatics, ELISpot assays, and HLA transgenic mice.
    McMurry JA; Kimball S; Lee JH; Rivera D; Martin W; Weiner DB; Kutzler M; Sherman DR; Kornfeld H; De Groot AS
    Curr Mol Med; 2007 Jun; 7(4):351-68. PubMed ID: 17584075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.